Abstract
Chronically epileptic cats and monkeys showed marked activation of paroxysmal electrographic abnormalities both in the original focus and in a number of structures with secondarily altered functional states after intraperitoneal injection of the serotonin precursor 5-hydroxytryptophan (10 to 25 mg/kg) plus vitamin B6. Much less 5-hydroxytryptophan was required to produce such epileptogenic activation if the animals had previously been treated with Marsilid, a monoamine oxidase inhibitor. Marked paroxysmal activity in epileptic animals was also produced by injection of Marsilid alone or of Marsilid in combination with reserpine. Since all of the activating agents used have been shown by others to elevate brain serotonin levels, the epileptogenic activation may be correlated with such high levels. Since the effects were at least partially blocked by atropine, such "serotonin-induced" activation may possibly involve some cholinergic mechanism.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
